A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2002
08/22/2002	CA2438658A1 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
08/22/2002	CA2438590A1 Therapeutic methods and agents for diseases associated with decreased expression of aop-1 gene or aop-1
08/22/2002	CA2438515A1 Methods and compositions for inhibiting hiv-coreceptor interactions
08/22/2002	CA2438219A1 Sequences involved in phenomena of tumour suppression, tumour reversion apoptosis and/or virus resistance and their use as medicines
08/22/2002	CA2438215A1 Putative human enzymes
08/22/2002	CA2438125A1 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof
08/22/2002	CA2437890A1 Methods and clinical devices for the inhibition or prevention of mammalian cell growth
08/22/2002	CA2437887A1 Methods of using mammalian rnase h and compositions thereof
08/22/2002	CA2437864A1 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial ib-367 peptides
08/22/2002	CA2437823A1 Acrochordon alleviation
08/22/2002	CA2437811A1 Human g-protein chemokine receptor (ccr5) hdgnr10
08/22/2002	CA2437358A1 Agonists and antagonists of sphingosine-1-phosphate receptors
08/22/2002	CA2437333A1 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin
08/22/2002	CA2436789A1 Identification of target-specific folding sites in peptides and proteins
08/22/2002	CA2436713A1 Proteins and nucleic acids encoding same
08/22/2002	CA2436452A1 A compound and method of treatment for fungal pathologies of the oral cavity
08/22/2002	CA2436259A1 Compounds effecting neuron remodeling and assays for same
08/22/2002	CA2436176A1 Thrombin inhibitors
08/22/2002	CA2436068A1 Thrombin inhibitors
08/22/2002	CA2434641A1 Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
08/22/2002	CA2433936A1 Localized myocardial injection method for treating ischemic myocardium
08/22/2002	CA2433843A1 Molecules for disease detection and treatment
08/22/2002	CA2433057A1 Butyrylcholinesterase polypeptide variants with increased catalytic efficiency and methods of use
08/22/2002	CA2432364A1 Bax-responsive genes for drug target identification in yeast and fungi
08/22/2002	CA2431033A1 Crystallization of igf-1
08/22/2002	CA2427741A1 Polynucleotide encoding a novel human potassium channel alpha-subunit, k+alpham1, and variants thereof
08/22/2002	CA2401383A1 Compositions of biochemical compounds involved in bioenergy metabolism of cells and method of use
08/21/2002	EP1233065A1 G-CSF analog compositions and methods
08/21/2002	EP1233064A1 Modified factor VIII cDNA and its use for the production of factor VIII
08/21/2002	EP1233025A1 Receptor expression cells and use thereof
08/21/2002	EP1233024A2 25466, a human transporter family member and uses therefor
08/21/2002	EP1233023A1 Transcription factor and dna thereof
08/21/2002	EP1233021A2 An inhibitor of Beta amyloid cleavage enzyme
08/21/2002	EP1232759A1 Gene transfer-mediated angiogenesis therapy
08/21/2002	EP1232758A1 Polynucleotide formulated for improved intracellular transfer
08/21/2002	EP1232755A2 Anti-HIV agents
08/21/2002	EP1232754A2 Use of cationic helix peptides for treatment of sepsis and for detection and removal of endotoxins
08/21/2002	EP1232753A1 Protein solution preparation and method of stabilizing the same
08/21/2002	EP1232744A1 Composition containing vitamin C prepared during application
08/21/2002	EP1232266A2 Polypeptides and nucleic acids encoding same
08/21/2002	EP1232264A2 Human fgf-21 gene and gene expression products
08/21/2002	EP1232263A2 Polypeptides and nucleic acids encoding same
08/21/2002	EP1232262A2 Recombinant gelatin in vaccines
08/21/2002	EP1232259A1 Human galanin family proteins and polynucleotides encoding the same
08/21/2002	EP1232257A2 Modular transport systems for molecular substances and production and use thereof
08/21/2002	EP1232254A1 Process for the production of a reversibly inactive acidified plasmin composition
08/21/2002	EP1232252A1 Reversibly inactivated acidified plasmin
08/21/2002	EP1232251A1 Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
08/21/2002	EP1232245A1 Gene and methods for diagnosing neuropsychiatric disorders and treating such disorders
08/21/2002	EP1232186A2 Antibody to human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin
08/21/2002	EP1232185A2 Methods of inhibiting metastasis
08/21/2002	EP1232183A2 Peptides having antiangiogenic activity
08/21/2002	EP1232181A2 Recombinant gelatins
08/21/2002	EP1232179A1 15 human secreted proteins
08/21/2002	EP1232178A2 Compositions and methods for regulating tumor-associated antigen expression
08/21/2002	EP1232177A2 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides
08/21/2002	EP1232176A1 Tumour suppressor factor
08/21/2002	EP1232175A2 Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof
08/21/2002	EP1232174A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals
08/21/2002	EP1232159A1 Beta-amyloid peptide inhibitors
08/21/2002	EP1231983A2 Treatment of subnormal bone mineral density
08/21/2002	EP1231943A1 Interferon gamma conjugates
08/21/2002	EP1231936A2 Methods and compositions for treatment of keratoconus using protease inhibitors
08/21/2002	EP1231935A2 Attenuation of tumor growth, metastasis and angiogenesis by use of chondroitin sulfate degrading enzymes
08/21/2002	EP1231934A2 Methods of inhibiting atrophy or promoting hypertrophy
08/21/2002	EP1231933A1 An aqueous solution formulation of alpha-interferon
08/21/2002	EP1231932A1 Implantable substrates for healing connective tissue
08/21/2002	EP1231931A2 Methods of treating inflammatory bowel disease using cholera toxin b subunit
08/21/2002	EP1231930A1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS
08/21/2002	EP1231927A2 Nontoxic vernix compositions and method of producing
08/21/2002	EP1231926A2 New complex, and methods for its production and use
08/21/2002	EP1231925A1 Method and composition for the treatment of adenoviral ocular infections
08/21/2002	EP1231923A1 Protease inhibitors
08/21/2002	EP1231913A2 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds
08/21/2002	EP1231907A2 Dextrose and insulin fluid formulation for intravenous infusion
08/21/2002	EP1231886A1 Topical skin composition
08/21/2002	EP1178835A4 Compositions and methods for improving learning and memory
08/21/2002	EP0983075B1 A method to increase the survival of transplanted cells
08/21/2002	EP0980251B1 Tissue factor for influencing blood vessel formation
08/21/2002	EP0966478A4 Novel hedgehog-derived polypeptides
08/21/2002	EP0956034B1 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxyethyl)-rapamycin
08/21/2002	EP0866654A4 Method for treating hepatitis virus infection
08/21/2002	EP0804456B1 Peptide nucleic acid conjugates
08/21/2002	EP0771192B1 Use of anti-vegf agents in the treatment of endometriosis
08/21/2002	EP0752882B1 Treatment for diabetes
08/21/2002	EP0644771B1 Erythropoietin drug delivery system
08/21/2002	EP0642580B1 Hepatocyte growth factor variants
08/21/2002	EP0637203B1 Regulation of the immune system
08/21/2002	EP0537160B1 Expression of recombinant hemoglobin in yeast
08/21/2002	CN1365395A Tenascin-C nucleic acid liqands
08/21/2002	CN1365392A Drosophila recombination-associated protein and methods for use
08/21/2002	CN1365389A MEG-3 protein
08/21/2002	CN1365293A Agents promoting the formation of skin basement, agents promoting the formation of artificial skin and process for producing artificial skin
08/21/2002	CN1365285A Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvia area
08/21/2002	CN1365284A Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
08/21/2002	CN1364904A New poypeptide-human glucosamino-6-phosphoisomerase 25.74 and polynucleotide for encoding such polypeptide
08/21/2002	CN1364903A New polypeptide-human glucosamino-6-phosphoisomerase 11.99 and polynucleotide for encoding such polypeptide
08/21/2002	CN1364902A New polypeptide-amidase family protein 16.06 and polynucleotide for encoding such polypeptide
08/21/2002	CN1364901A New polypeptide-arginase 8.91 and polynucleotide for encoding such polypeptide
08/21/2002	CN1364900A New polypeptide-human ATP dependent serine protein hydrolase 47.19 and polynucleotide for encoding such polypeptide

1 ... 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 ... 3163